Geoffrey Gonzales
Psychiatric/Mental Health · San Antonio, TXNPI 1093030512
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $34,656 of the $56,839 with a category attached, or 61.0%. Teva Pharmaceuticals USA, Inc. accounts for 74.6% of it on its own, with 25 other manufacturers making up the rest. Among psychiatric/mental health clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,010 payments — averaging $56.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$42K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$3K
- Johnson & Johnson$2K
- Otsuka America Pharmaceutical, Inc.$2K
- Neurocrine Biosciences, Inc.$2K
- AbbVie$2K
- plus $5K from 20 others
What the payments were for
- Consulting fees$3301%
- Speaking & faculty fees$34,65661%
- Travel & lodging$4,4968%
- Food & beverage$17,22030%
- Education$1370%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 176 | $42,394 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 131 | $2,685 |
| Johnson & Johnson(2 entities) | 100 | $1,908 |
| Otsuka America Pharmaceutical, Inc. | 125 | $1,718 |
| Neurocrine Biosciences, Inc. | 62 | $1,573 |
| AbbVie | 123 | $1,537 |
| Alkermes, Inc. | 62 | $1,300 |
| Lundbeck LLC | 53 | $668 |
| Vanda Pharmaceuticals Inc. | 29 | $512 |
| Sunovion Pharmaceuticals Inc. | 32 | $468 |
| Axsome Therapeutics, Inc. | 24 | $366 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $282 |
| Avanir Pharmaceuticals, Inc. | 19 | $262 |
| E.r. Squibb & Sons, L.L.C. | 8 | $204 |
| Idorsia Pharmaceuticals US Inc | 14 | $181 |
| Eisai Inc. | 4 | $159 |
| Almatica Pharma LLC | 6 | $140 |
| Bausch Health US, LLC | 7 | $111 |
| Merck | 7 | $99 |
| Mallinckrodt Hospital Products Inc. | 1 | $83 |
| Outset Medical Inc | 1 | $74 |
| Indivior Inc. | 3 | $42 |
| Medtronic | 1 | $19 |
| Noven Therapeutics, LLC | 1 | $19 |
| Pfizer | 1 | $19 |
| Si-bone, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Austedo XR$37,697
- AUSTEDO$2,512
- INGREZZA$736
- CAPLYTA$500
- ABILIFY MAINTENA$237
- Fanapt$125
- ABILIFY ASIMTUFII$122
- Dayvigo$113
- SPRAVATO$108
How this compares
$56,839 in reported general payments places this provider in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 32 | $253,066 |
| IngrezzaValbenazine Tosylate | 26 | $224,599 |
| Invega TrinzaPaliperidone Palmitate | 17 | $172,312 |
| VraylarCariprazine Hcl | 90 | $145,425 |
| LybalviOlanzapine/Samidorphan Malate | 47 | $84,827 |
| Invega SustennaPaliperidone Palmitate | 31 | $83,262 |
| RexultiBrexpiprazole | 49 | $78,277 |
| CaplytaLumateperone Tosylate | 44 | $75,569 |
| SpravatoEsketamine Hcl | 35 | $73,679 |
| TrintellixVortioxetine Hydrobromide | 90 | $73,307 |
| Abilify MaintenaAripiprazole | 15 | $36,773 |
| LatudaLurasidone Hcl | 13 | $27,967 |
| AuvelityDextromethorphan Hbr/Bupropion | 16 | $27,093 |
| FanaptIloperidone | 12 | $23,638 |
| BelsomraSuvorexant | 26 | $18,065 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Trinza, Invega Sustenna, Spravato | $1,908 | $329,25283 claims |
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $42,394 | $253,06632 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $1,573 | $224,59926 claims |
| AbbVieVraylar | $1,537 | $145,42590 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena | $1,718 | $115,05064 claims |
| Alkermes, Inc.Lybalvi | $1,300 | $84,82747 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $2,685 | $75,56944 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $282 | $73,30790 claims |
| Sunovion Pharmaceuticals Inc.Latuda | $468 | $27,96713 claims |
| Axsome Therapeutics, Inc.Auvelity | $366 | $27,09316 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $512 | $23,63812 claims |
| MerckBelsomra | $99 | $18,06526 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.
Other psychiatric/mental health in San Antonio
- Monique GonzalezSan Antonio$126K
- Sara Koenig LangstonSan Antonio$27K
- Peter TorciviaSan Antonio$13K
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
- Marguerite AddisonWaco$118K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.